Tirzepatide

Tirzepatide is a synthetic dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist studied for its interaction with incretin receptor signaling pathways in experimental metabolic models. It is structurally engineered to enhance stability and receptor affinity. Preclinical research utilizes Tirzepatide to investigate receptor binding kinetics, cAMP-mediated intracellular signaling cascades, and coordinated endocrine pathway modulation under controlled laboratory conditions.

For research use only. Not for human consumption.